PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

Abstract : Multiple myeloma (MM) is a hematological neoplasm characterized by the clonal proliferation of malignant plasma cells in the bone marrow. MM results in diffuse or focal bone infiltration and extramedullary lesions. Over the past two decades, advances have been made with regard to the diagnosis, staging, treatment, and imaging of MM. Computed tomography (CT) and magnetic resonance imaging (MRI) are currently recommended as the most effective imaging modalities at diagnostic. Yet, recent data from the literature suggest that positron emission tomography combined with computed tomography (PET/CT) using 18 F-deoxyglucose (FDG) is a promising technique for initial staging and therapeutic monitoring in this pathology. This paper reviews the recent advances as well as the potential place of a more specific radiopharmaceutical in MM.
Type de document :
Article dans une revue
International Journal of Molecular Sciences, MDPI, 2017, 18 (2), pii: E445. 〈10.3390/ijms18020445〉
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01500327
Contributeur : Elizabeth Bernardo <>
Soumis le : lundi 3 avril 2017 - 09:52:41
Dernière modification le : vendredi 19 octobre 2018 - 10:02:01

Fichier

Bailly2017Eq13.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Clément Bailly, Rodolphe Leforestier, Bastien Jamet, Thomas Carlier, Mickael Bourgeois, et al.. PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. International Journal of Molecular Sciences, MDPI, 2017, 18 (2), pii: E445. 〈10.3390/ijms18020445〉. 〈inserm-01500327〉

Partager

Métriques

Consultations de la notice

170

Téléchargements de fichiers

103